Banque Transatlantique’s Organon & Co OGN Stock Holding History

Banque Transatlantique’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.01K	Sell	74 -97	-57%	-$1.32K	﹤0.01%	476
2026 Q2	$1.75K	Buy	171 +60	+54%	+$717	﹤0.01%	479
2026 Q1	$676	Hold	111	–	–	﹤0.01%	433
2025 Q4	$796	Hold	111	–	–	﹤0.01%	254
2025 Q3	$1.18K	Sell	111 -4	-3%	-$39	﹤0.01%	250
2025 Q2	$1.12K	Hold	115	–	–	﹤0.01%	235
2025 Q1	$1.71K	Sell	115 -20	-15%	-$308	﹤0.01%	216
2024 Q4	$2K	Buy	+135	New	+$2.2K	﹤0.01%	248

Other funds holding OGN

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 22.91% 1-Year Est. Return

Banque Transatlantique's OGN Position: Q3 2026 in Review

Banque Transatlantique reduced its Organon & Co (OGN) stake by 57% in Q3 2026, selling an estimated $1.32K and leaving 74 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #476.

Banque Transatlantique first reported a position in OGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $2K in Q4 2024. 465 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

Banque Transatlantique held 74 shares of Organon & Co worth $1.01K as of Q3 2026.
Banque Transatlantique sold 97 Organon & Co shares in Q3 2026, an estimated $1.32K.
Organon & Co made up ﹤0.01% of Banque Transatlantique's portfolio in Q3 2026, its #476 holding.
Banque Transatlantique first reported a position in Organon & Co in Q4 2024 and has held it in 8 quarters since.
Banque Transatlantique's Organon & Co position peaked at $2K in Q4 2024.
465 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Banque Transatlantique's 13F filing for Q3 2026, filed 10 Nov 2026.